-
srdr.ahrq.gov/projects/1671/studies/196129
January 01, 2019 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196111
January 01, 2019 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196119
January 01, 2019 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196182
January 01, 2019 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1312/studies/133289
January 01, 2012 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1565/studies/198068
January 01, 2020 - obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular … obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular … Cardiovascular events
Comments ( 0 ) |
Post/View
-
srdr.ahrq.gov/projects/1712/studies/197905
January 01, 2011 - Country
Institut National de la santé et de la Recherche Médicale, U970 (Cardiovascular Research
-
srdr.ahrq.gov/projects/1671/studies/196168
January 01, 2019 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1565/studies/189206
January 01, 2015 - Comorbidities
Cardiovascular disease
Cardiovascular disease
-
srdr.ahrq.gov/projects/1312/studies/133146
January 01, 2014 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1312/studies/133280
January 01, 2015 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1312/studies/147771
January 01, 2017 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1671/studies/196176
respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1312/studies/133206
January 01, 2015 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1312/studies/175426
January 01, 2015 - Key Questions Addressed
1
Is dietary intake of flavan-3ols associated with cardiovascular … Comments ( 0 ) |
Post/View
Cardiovascular
-
srdr.ahrq.gov/projects/1671/studies/196180
respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196158
January 01, 2006 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196167
January 01, 2005 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196181
January 01, 2010 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related
-
srdr.ahrq.gov/projects/1671/studies/196161
January 01, 1994 - respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including gastrointestinal-related harms, cardiovascular-related